Er-Lei Zhang Zun-Yi Zhang Jian Li Zhi-Yong Huang
10.2147/OTT.S284092
Onco Targets Ther
2020 Dec 4;13:12477-12487.
pd-1 inhibitor hepatocellular carcinoma regorafenib sorafenib sorafenib-refractory
CC BY-NC
https://pubmed.ncbi.nlm.nih.gov/33311988/
Case Reports
PMC7727032
33311988
Complete Response to the Sequential Treatment with Regorafenib Followed by PD-1 Inhibitor in a Sorafenib-Refractory Hepatocellular Carcinoma Patient
2020